Fri, January 20, 2023
Thu, January 19, 2023
Wed, January 18, 2023
Tue, January 17, 2023
Mon, January 16, 2023
Sat, January 14, 2023
Fri, January 13, 2023

Marc Solecitto Maintained (TDOC) at Hold with Decreased Target to $28 on, Jan 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-28-on-jan-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Marc Solecitto of Barclays, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $32 to $28 on, Jan 18th, 2023.

Marc has made no other calls on TDOC in the last 4 months.



There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 6 agree with Marc's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $33 on, Tuesday, December 13th, 2022
  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $30 on, Monday, October 31st, 2022
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $32 on, Thursday, October 27th, 2022
  • Sandy Draper of "Guggenheim" Upgraded from Strong Sell to Hold on, Monday, October 24th, 2022
  • Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $29 on, Friday, October 21st, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022


These are the ratings of the 2 analyists that currently disagree with Marc


  • Robert Simmons of "DA Davidson" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, October 25th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022

Publication Contributing Sources